Brown & Brown Investing Cash Flow increased by 82.2% to -$38.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.9%, from -$79.00M to -$38.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 111.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$82.40M | -$53.90M | -$70.10M | -$190.40M | -$445.80M | -$21.70M | -$1.45B | -$400.00K | -$43.00M | -$91.00M | -$59.00M | -$394.00M | -$88.00M | $0.00 | -$42.00M | -$779.00M | -$79.00M | -$108.00M | -$7.51B | -$213.00M | -$38.00M |
| QoQ Change | — | +34.6% | -30.1% | -171.6% | -134.1% | +95.1% | <-999% | +100.0% | <-999% | -111.6% | +35.2% | -567.8% | +77.7% | +100.0% | — | <-999% | +89.9% | -36.7% | <-999% | +97.2% | +82.2% |
| YoY Change | — | — | — | — | -441.0% | +59.7% | <-999% | +99.8% | +90.4% | -319.4% | +95.9% | <-999% | -104.7% | +100.0% | +28.8% | -97.7% | +10.2% | — | <-999% | +72.7% | +51.9% |